Literature DB >> 28647828

3D printing of severe hypertrophic cardiomyopathy in a child with Rasopathy.

N F Johnston1, T Prendiville1, C J McMahon2.   

Abstract

We describe the use of 3D printing in conjunction with echocardiography in assessing hypertrophic cardiomyopathy in a boy with Rasopathy. 3D printing may supplement conventional imaging including echocardiography and MRI in the evaluation of hypertrophic cardiomyopathy.

Entities:  

Mesh：

Year:  2017        PMID： 28647828     DOI： 10.1007/s11845-017-1646-4

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


  3 in total

1.  PTPN11 gene mutations: linking the Gln510Glu mutation to the "LEOPARD syndrome phenotype".

Authors:  M Cristina Digilio; Anna Sarkozy; Giuseppe Pacileo; Giuseppe Limongelli; Bruno Marino; Bruno Dallapiccola
Journal:  Eur J Pediatr       Date:  2006-05-30       Impact factor: 3.183

2.  A novel mutation in the PTPN11 gene in a patient with Noonan syndrome and rapidly progressive hypertrophic cardiomyopathy.

Authors:  Kunihiko Takahashi; Shigetoyo Kogaki; Shunji Kurotobi; Sayaka Nasuno; Makiko Ohta; Hitomi Okabe; Kazuko Wada; Norio Sakai; Masako Taniike; Keiichi Ozono
Journal:  Eur J Pediatr       Date:  2005-05-12       Impact factor: 3.183

3.  Rapidly progressive hypertrophic cardiomyopathy in an infant with Noonan syndrome with multiple lentigines: palliative treatment with a rapamycin analog.

Authors:  Andreas Hahn; Jessica Lauriol; Josef Thul; Kachina Behnke-Hall; Tushiha Logeswaran; Anne Schänzer; Nuray Böğürcü; Boyan K Garvalov; Martin Zenker; Bruce D Gelb; Susanne von Gerlach; Reinhard Kandolf; Maria I Kontaridis; Dietmar Schranz
Journal:  Am J Med Genet A       Date:  2015-02-23       Impact factor: 2.802
  3 in total
  1 in total

1.  Application of 3D printing in the surgical planning of hypertrophic obstructive cardiomyopathy and physician-patient communication: a preliminary study.

Authors:  Hong-Chang Guo; Yang Wang; Jiang Dai; Chang-Wei Ren; Jin-Hua Li; Yong-Qiang Lai
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.